TERT and melanoma: Recurrent non-coding mutations have been identified at two primary locations in the promoter of the human telomerase reverse transcriptase (TERT) gene in melanomas and other cancers10–12, both of which up-regulate TERT expression and telomerase activity13–15 by creating a binding site for E26 transformation-specific (ETS) family transcription factors (TF).